COMMUNIQUÉS West-GlobeNewswire

Zynerba Pharmaceuticals Announces Sustained Improvements in Emotional and Behavioral Symptoms of Fragile X Syndrome through 12 Months of Treatment with ZYN002

12/12/2018 - 23:30

- Patients Experienced a 77% Improvement in Aberrant Behaviors Associated with Social Avoidance Compared to Baseline after One Year of ZYN002 Treatment - - Presentation Today at the 57th Annual Meeting of the American [...]

Synthorx Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

12/12/2018 - 22:05

SAN DIEGO, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Synthorx, Inc. (Nasdaq: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics for [...]

Idera Pharmaceuticals to Provide ILLUMINATE-204 Clinical Data Update on Friday, December 14, 2018

12/12/2018 - 22:01

EXTON, Pa., Dec. 12, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical-stage biopharmaceutical company focused on the development and ultimate commercialization of drug candidates for both [...]

AGTC Announces Topline Interim Six-Month Data from Phase 1/2 X-Linked Retinoschisis Clinical Study; Termination of Biogen Collaboration

12/12/2018 - 22:01

- Results from XLRS study support general safety and tolerability of AGTC’s gene delivery platform but did not demonstrate signs of clinical activity at interim six-month time point - - AGTC to regain rights to five [...]

VBI Vaccines Announces Proposed Public Offering of Common Shares

12/12/2018 - 22:01

CAMBRIDGE, Mass., Dec. 12, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today [...]

Improved Accuracy and Speed for Disease Research, Two Genomic Companies Integrate Kits and Software to Enable Deep Exploration of Epigenetic Data

12/12/2018 - 21:16

OnRamp’s ROSALIND and Active Motif offer an improved ChIP-Seq data analysis experience for researchers with state-of-the-art dynamics track plots and advanced collaboration capabilities SAN DIEGO, Dec. 12, 2018 (GLOBE [...]

Alkaline Water: A Well-Known Brand Enters the CBD Space -- CFN Media

12/12/2018 - 19:46

SEATTLE, Dec. 12, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]

Advanzeon Solutions, Inc.’s Wholly-Owned Subsidiary Pharmacy Value Management Solutions, Inc. Announces Medical Director and Members of Its Medical Advisory Board Voted Top Doctors by Peers

12/12/2018 - 18:06

TAMPA, Fla., Dec. 12, 2018 (GLOBE NEWSWIRE) -- Advanzeon Solutions, Inc.’s (OTCBB:CHCR) ("Advanzeon") wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. ("PVMS") (collectively, the "Company"), announced [...]

Easton Pharmaceuticals Provides Company Update Including Hotel Acquisition in Toronto, BAYER Agreement and Casino Resort in Greece

12/12/2018 - 17:34

TORONTO, ON, Dec. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH ) Provides Company update including Hotel Acquisition in Toronto, BAYER Distribution Agreement for Mexico, as [...]

Ambu A/S: Articles of Association December 2018

12/12/2018 - 16:41

Attached Complete Articles of Association December 2018 Attachment Complete Articles of Association December 2018.pdf

Aptose Presents Highlights From CG-806 KOL Event

12/12/2018 - 16:00

Dr. Brian Druker Reviews AML and B-cell Cancer Treatment Landscape and Provides Update on Novel Multi-Cluster Kinase Inhibitor CG-806 SAN DIEGO and TORONTO, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ( [...]

CMR Surgical and Florida Hospital Nicholson Center Launch First Training Program in the U.S. for New Surgical Robotic System, Versius®

12/12/2018 - 15:03

The high-tech surgical training facility is the first in the U.S. to partner with the British robotics company to train surgeons with the next-generation robotic system Versius® CAMBRIDGE, United Kingdom and CELEBRATION [...]

Ceapro Inc. Presents PGX Technology at the Society of Cosmetic Chemists’ 72nd Annual Scientific Meeting and Technology Showcase

12/12/2018 - 15:00

EDMONTON, Alberta, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. ( TSX-V: CZO) (“Ceapro” or the “Company”) , a growth-stage biotechnology company focused on the development and commercialization of active ingredients [...]

Phoenix Life Sciences International Is Now Accepting Bids for Hemp CBD Producers and Manufacturers

12/12/2018 - 15:00

DENVER, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that it is now accepting bids [...]

Assessing MediPharm Labs' Sales Agreement with Canopy Growth -- CFN Media

12/12/2018 - 15:00

SEATTLE, Dec. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

iAnthus and MPX Announce Receipt of Interim Court Order

12/12/2018 - 14:56

NEW YORK and TORONTO, Dec. 12, 2018 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or “the Company”), (CSE: IAN, OTCQB: ITHUF) and MPX Bioceutical Corporation (“MPX”) (CSE: MPX; OTC:MPXEF) announced today [...]

CV Sciences, Inc. Receives Nutritional Outlook’s 2018 Best of the Industry Award

12/12/2018 - 14:45

Company’s industry-dominating hemp extract brand, PlusCBD Oil™ wins Best Retail/Brand Product category LAS VEGAS, Dec. 12, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB: CVSI) (the “Company”, “CV Sciences”, “our” or [...]

Cell Therapy Industry Pioneer, Gwendolyn Binder, Ph.D., to Join Cabaletta Bio Leadership Team

12/12/2018 - 14:30

Dr. Binder is an expert in T cell product development, translational research and GMP manufacturing Joins Cabaletta Bio as Executive Vice President, Science & Technology on February 1, 2019 RADNOR, Pa., Dec. 12, [...]

Adaptimmune Announces that Gwen Binder will leave in January 2019

12/12/2018 - 14:30

PHILADELPHIA and OXFORD, United Kingdom, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Adaptimmune (Nasdaq: ADAP), a leader in T-cell therapy to treat cancer, today announced that Gwen Binder, PhD, Chief Technology Officer, will be [...]